SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $293,000 | -14.3% | 6,602 | +9.6% | 0.01% | -25.0% |
| Q2 2021 | $342,000 | +2.1% | 6,026 | +34.5% | 0.01% | +14.3% |
| Q1 2021 | $335,000 | -16.9% | 4,481 | -3.9% | 0.01% | -12.5% |
| Q4 2020 | $403,000 | +30.8% | 4,663 | -7.5% | 0.01% | 0.0% |
| Q3 2020 | $308,000 | +48.8% | 5,042 | +1.1% | 0.01% | +33.3% |
| Q2 2020 | $207,000 | -31.2% | 4,986 | -50.1% | 0.01% | -73.9% |
| Q2 2016 | $301,000 | -60.0% | 10,000 | -33.3% | 0.02% | -30.3% |
| Q1 2015 | $753,000 | – | 15,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |